Full-Time
Global IP and litigation law firm
$30 - $36.50/hr
Santa Monica, CA, USA
In Person
See people who can refer or advise you
Cooley is a large international law firm that helps clients with major deals, complex intellectual property work, regulatory issues, and high-stakes lawsuits. Its lawyers across 19 offices in the U.S., Asia, and Europe collaborate to advise on transactions, protect and manage IP assets, navigate regulations, and represent clients in court or arbitration. The firm differentiates itself by its sizeable global team and wide range of practice areas, allowing it to handle complex matters that cross markets and jurisdictions. Cooley’s goal is to help clients complete transformative deals, secure strong IP positions, meet regulatory requirements, and win important litigation outcomes.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Boston, Massachusetts
Founded
1920
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
Parental Leave
Fertility Treatment Support
Hybrid Work Options
Commercial litigator heads to King & Spalding. King & Spalding has added disputes firepower in New York with the appointment of an 'outstanding' lawyer from Cooley. Trial lawyer Philip Bowman has bid farewell to Cooley after an eight-year tenure to join Cooley's New York-based business litigation practice as partner. The hire was confirmed today (3 September). With a focus on high-stakes commercial litigation, Bowman frequently represents clients in proceedings relating to life sciences collaboration and licensing, mergers and acquisitions (M&A), antitrust, trade secret and restrictive covenant issues, as well as litigation involving clients in the private equity, investment management, venture capital and technology sectors. Bowman acts before both state and federal courts across the US, as well as in domestic and international arbitrations. "Phil is an outstanding trial lawyer with a sophisticated commercial litigation practice that aligns closely with many of the firm's strategic priorities and enhances our ability to handle complex disputes across a range of industries," said Damien Marshall, co-leader of King & Spalding's Business Litigation practice group. "Phil's arrival enhances our bench in New York, expands opportunities for collaboration across practices, and demonstrates King & Spalding's continued investment in our premier litigation platform." Bowman began his legal career with a four-year stint at Cravath, Swaine & Moore, before departing for Boies Schiller Flexner in 2006. He went on to spend 12 years at Boies Schiller before joining Cooley in 2018. It has been a busy year for King & Spalding on the lateral hire front, with 64 partners welcomed to the firm over the past nine months, including 23 additions to the business litigation practice group. Notable appointments include those of Sydney-based regulatory and disputes lawyer Mandi Jacobson, Dallas-based litigation partners LeElle Slifer, John Sullivan and Katrina Eash, a US litigation team led by global trial head Tom Melsheimer, and Atlanta-based product liability and mass torts partner Rebeca Ojeda. This week alone has seen two other lateral hires welcomed to the firm with the arrival of international arbitration partner Thomas Voisin in Paris and private equity M&A partner Nicola Yeomans in Singapore.
Superluminal Medicines has closed an oversubscribed $60 million Series B financing led by BVF Partners, with participation from Deep Track Capital and Perceptive Advisors alongside existing investors including RA Capital Management, Insight Partners, and NVIDIA. The Boston-based biotechnology company will use the proceeds to advance its lead programme — a selective MC4R agonist for rare genetic forms of obesity and hypothalamic obesity — into a Phase 1 clinical trial by the end of 2026. The funding will also support expansion of its GPCR-focused discovery platform. Superluminal integrates AI, machine learning, and structural biology to develop small-molecule therapies targeting G protein-coupled receptors for endocrine and cardiometabolic diseases. The company maintains a strategic collaboration with Eli Lilly for advancing GPCR-targeted therapeutics.
Cooley advised lynk global on merger with omnispace, concurrent investments and partnerships with SES and nelco. August 18, 2026 Results 1-3 of 3 Cooley cookie preferences. At Cooley, Cooley LLP use a variety of technologies to help Cooley LLP deliver customized web visitor experiences. In particular, Cooley LLP may use a technology called "cookies" to provide you with, for example, customized information from our website and its webpages. You can update your consent in our Cookie Preference Center at any time. By clicking "Accept all," you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in its marketing efforts. View its cookie policy. View its legal notices.
Sidley Austin taps Cooley for life sciences transactions partner. Published on 13/08/2026 A lawyer specialising in IP-focused commercial deals joins Sidley in New York. Global law firm Sidley Austin has bolstered its life sciences transactions practice with the appointment of Jiqiang Lin as partner. The hire was confirmed yesterday (12 August). Lin joins the firm's New York office following a four-year stint at international law firm Cooley, where he was recently promoted to senior counsel in March 2026. With a client base including biotechnology, pharmaceutical and other life science companies, including China-based businesses, Lin specialises in complex intellectual property-focused commercial deals. His US and cross-border practice spans licensing arrangements, strategic collaborations and related transactions focused on the growth and commercialisation of innovative technologies and therapies. Lin's work also extends to advising on manufacturing and supply, research and development, distribution and commercialisation agreements, as well as commercial and intellectual property matters related to public offerings and mergers and acquisitions, as well as other strategic investments. In his earlier career, Lin served as an associate at global law firm Latham & Watkins and as a regulatory intern at biopharmaceutical giant Pfizer. Sidley's management committee chair Yvette Ostolaza described Lin as an "outstanding life sciences transactions lawyer with experience advising on some of the industry's most innovative licensing, collaboration and partnering transactions". "[Lin's] arrival further expands our transactional life sciences practice on the East Coast, adding to the recent growth in our practice in Boston and New York," added global life sciences head Sharon Flanagan. "His combination of sophisticated scientific credentials and extensive experience advising on high stakes matters will enhance our ability to counsel clients on complex transactions involving cutting-edge therapeutic platforms, biologics, immunology, oncology, gene therapy, and other advanced technologies." Sidley previously poached talent from Cooley in March 2026, hiring San Diego-based partner Steven Przesmicki in a boost to its corporate and securities capabilities. Related firms. Related publications.
Webinar: A practitioner's perspective on building connected legal workflows. * August 12, 2026 Legal technology has never been more powerful, yet many firms and legal departments still find themselves wrestling with fragmented systems, disconnected workflows and an ever-growing list of tools. Join, Caroline Hill, editor-in-chief of Legal IT Insider, and Tara Daisy managing director, legal of Box, for an organic chat about Daisy's experience of using Box at Cooley and her insights into how firms can move beyond individual point solutions and create more connected, streamlined and intelligent ways of working. Daisy joined Box in May after eight years at Cooley, latterly as director of data delivery. Her earlier knowledge and projects career includes roles at Kirkland & Ellis and Hogan Lovells Cadwalader. This isn't a demo but a conversation around the growing convergence of the business and practice of law, the role of AI and knowledge management, and how legal teams can better manage content, collaboration and information across the entire matter lifecycle. Join Legal Technology for real-world perspectives and plenty of ideas you can take away and apply in your own organisation. Please bring your questions too. Thursday 10th september.